Lysophosphatidic acid (LPA) is a lipid mediator that may play an important role in growth and survival of carcinomas. In this study, LPA production and response were characterized in two human prostate cancer (CaP) cell lines: PC-3 and Du145. Bombesin, a neuroendocrine peptide that is mitogenic for CaP cells, stimulated focal adhesion kinase phosphorylation and activated the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway. Similar responses were elicited by 18:1 LPA (oleoyl-LPA). Studies using radioisotopic labeling revealed that both PC-3 and Du145 generate LPA and that LPA production is increased by bombesin. The kinetics of bombesin-induced phospholipase D activation and LPA production were similar. Using electrospray ionization mass spectrometry, 18:1 LPA was found to be an abundant LPA species in CaP cell medium. Structure activity studies of acyl-LPAs revealed that 18:1 LPA is most efficacious for activation of extracellular signal-regulated kinase and phospholipase D in CaP cells. Incubation with 18:1 LPA caused homologous desensitization of LPA response, whereas bombesin caused heterologous desensitization. LPA was present at nanomolar levels in medium from bombesin-treated cells. LPA extracted from the medium induced calcium mobilization in CaP cells. These results demonstrate that bioactive LPA is generated by CaP cells in response to a mitogen and suggest that 18:1 LPA can act as an autocrine mediator.
Lysophosphatidic acid (LPA) 1 is a lipid mediator generated via the regulated breakdown of membrane phospholipids. LPA binds to G protein-coupled receptors encoded by the Edg gene family to exert diverse biological effects (1) . Growth-promoting activity of LPA has been observed in numerous cell lines (2) . The ability of serum to induce mitosis appears to be mediated, in large part, by the lipids LPA and sphingosine-1-phosphate (S1P). S1P is a lipid with a similar overall structure to LPA but with a sphingosine backbone rather than a glycerol backbone (3, 4) . S1P can act as an autocrine mediator of cell migration in fibroblasts (5) .
Although LPA was first shown to be released by activated platelets, many cell types have now been shown to produce LPA (reviewed in Ref. 6 ). Because LPA receptors are widely expressed in embryonic and adult tissues (7) , LPA can potentially act as both a paracrine and autocrine mediator. For example, LPA is produced by adipocytes and can serve as a paracrine mediator to stimulate proliferation of preadipocytes (8) . Ascites fluid from ovarian cancer patients contain elevated levels of LPA (9, 10) . Ovarian cancer cells can produce and respond to LPA (11) . Moreover, vascular endothelial growth factor released from ovarian cancer cells in response to LPA can induce angiogenesis in endothelial cells (12) . These latter findings suggest that LPA can act as an paracrine and/or autocrine growth factor in tumors.
The metabolic pathways involved in LPA production have not been well defined. Possibilities include: 1) hydrolysis of phosphatidylcholine to phosphatidic acid (PA) by phospholipase D (PLD), followed by hydrolysis of PA by a phospholipase A 2 (PLA 2 ), 2) generation of lyso-phospholipid by PLA 2 , followed by hydrolysis by a lyso-PLD, and 3) phosphorylation of monoglyceride by monoglyceride kinase. The agonist-regulated steps in these pathways have not yet been defined. Nonetheless, it is clear that production of LPA can be stimulated as a result of receptor-mediated signal transduction (reviewed in Ref. 6) .
LPA refers to a family of glycerophospholipids with carbon chains of varying length and saturation linked to glycerol by acyl, alkyl, or alkenyl linkages. Research concerning the structure activity relationship of LPAs has been complicated by the numerous possible variations in its composition. The phosphate head group is critical for LPA activity, whereas manipulations of the lipophilic substituent and its linkage to the glycerol backbone have variable effects on LPA activity in different systems (13) . The fact that cells typically express multiple LPA receptors with overlapping but distinct ligand specificities (14) suggests that response profiles for LPA species will differ between cell types according to their receptor expression.
Oleoyl-LPA (1-acyl 18:1 LPA), a species present in biological samples, is most often used experimentally as an agonist. Studies have shown that 18:1 LPA and 16:0 LPA are most efficacious at inducing a variety of cellular responses (15) . We previously reported that 18:1 LPA is mitogenic for prostate cancer (CaP) cells (16) and that PC-3 and Du145, two human CaP cell lines, express the LPA receptors LPA 1 /Edg-2 and LPA 2 /Edg-4, but not LPA 3 /Edg-7 (17) . 2 Mitogenic responses of PC-3 cells to LPA have been confirmed by others (18, 19) . Our work has also shown that CaP cells can generate LPA (20) . Based on these findings, we hypothesize that LPA serves as an autocrine growth factor in human CaP cells. In this report, we provide evidence that: 1) extracellular 18:1 LPA is generated by CaP cells, 2) LPA levels are increased by bombesin, 3) bombesin induces desensitization of LPA response, and 4) LPA produced in response to bombesin is biologically active. Cell Culture-PC-3 cells and Du145 cells obtained from American Type Culture Collection (Manassas, VA) were maintained in F12K and RPMI 1640 media, respectively, supplemented with 10% fetal bovine serum (Invitrogen). The cells were grown at 37°C in 5% CO 2 , 95% air on standard tissue culture plastic and serum-starved by incubation in serum-free medium for 18 -24 h.
EXPERIMENTAL PROCEDURES

Materials-LPAs
Isotopic Method for LPA Analysis-LPA production was assessed in cells and medium as described previously (20) . Briefly, the cells grown in 6-well plates, with replicate wells for each treatment, were serumstarved and simultaneously labeled by incubation for 18 h with 5 Ci/ml 3 HLabeled lipids were visualized by autoradiography after spraying with ENhance. LPA bands, as well as the remainder of each lane, were scraped and quantitated by liquid scintillation spectrometry. The results are expressed as percentages of the total radioactivity recovered.
Mass Spectrometry-LPA extraction and separation were done as described above but without radioisotope labeling. LPA bands were scraped from the TLC plate and then eluted from the silica using chloroform/methanol (1:1 v/v). The samples were dried under nitrogen and dissolved in methanol. ESI-MS and tandem MS (MS/MS) were performed on a LCQ TM ion trap mass spectrometer equipped with an ESI source (Finnigan Corp., San Jose, CA). The samples were delivered into the ESI source using a syringe pump via direct infusion. The mobile phase was methanol/H 2 O (1:1 v/v); flow rate was 5 l/min. The capillary temperature was maintained at 200°C. LPA was detected in the negative mode with a capillary voltage of Ϫ17 V. The tube lens offset voltage was 10 V. The collision energies were 28% for MS/MS. To validate MS/MS spectra, 17:0, 18:1, and 16:0 LPAs were used as standards.
Radioenzymatic Assay for Bulk LPA-An assay for bulk LPA levels was carried out according to the method of Saulnier-Blache and coworkers (21) . Briefly, this assay involves conversion of unlabeled LPA to [ 14 C]PA using bacterially expressed mammalian LPA acyltransferase. The LPA acyltransferase construct was kindly provided by Dr. J. S. Saulnier-Blache (INSERM, Toulouse, France) with the permission of Dr. K. Kume (University of Tokyo). LPA was extracted from CaP cell medium as described above for the isotopic assay. Medium from one 150-mm dish of cells (12 ml) was used for each experimental treatment. In some experiments, the medium was incubated with phospholipase B (PLB) (0.2 unit/ml; Sigma) for 12 h at 37°C prior to lipid extraction; the controls were incubated similarly, without PLB. The lipid extracts were dried and then suspended in assay buffer containing Tween 20, [ 14 C] oleoyl-CoA (PerkinElmer Life Sciences), and microsomal membranes from Escherichia coli expressing murine LPA acyltransferase (22) . Following incubation, the lipids were extracted and separated by TLC. The [ 14 C]PA band was localized by autoradiography and then quantitated by densitometry using NIH Image software.
Intact Cell PLD Assay-PLD assays were performed in intact cells by methods described previously (23) . The materials and procedures for this assay are similar to those described above for isotopic LPA analysis. Briefly, the cells were grown in 6- Immunoblotting-Whole cell extracts, prepared from cells treated with and without agonists, were subjected to SDS-PAGE and immunoblotting as described previously (24) . The blots were developed using enhanced chemiluminescence reagents (Amersham Biosciences).
Calcium Mobilization Assay-LPA-induced calcium mobilization was analyzed as described previously by Heise and colleagues (25) . The lipids were extracted from CaP cell medium as described above for the radioenzymatic LPA assay; the media from three 150-mm dishes were combined for each experimental condition. For some experiments, the medium was incubated with phospholipase B prior to extraction as described above for the radioenzymatic assay. The lipid extract was suspended in 20 mM HEPES (pH 7.4) before use in the bioactivity assay. PC-3 cells (2 ϫ 10 4 cells/well) were plated in clear bottom black 96-well plates overnight and then serum-starved for 18 -24 h. The cells were loaded with Fluo3-AM ester (Molecular Probes) in a loading buffer for 1 h at 37°C, washed four times with the loading buffer, and then incubated with various concentrations of LPA standards and lipid extract using a fluorometric imaging plate reader (Molecular Devices). Five to six replicate wells were analyzed for each experimental condition. The data were analyzed using the fluorometric imaging plate reader software with appropriate negative control corrections.
RESULTS
Effects of Bombesin and 18:1 LPA on Signal Transduction in
Human CaP Cells-The first question that we addressed was whether LPA is produced by prostate cancer cells in response to a mitogenic agonist. Although previous work in our lab had established that 18:1 LPA is mitogenic for PC-3 cells (16), an alternative agonist was needed for studies of mitogen-induced LPA production. Bombesin, a peptide mitogen for CaP cells (26) , is secreted by neuroendocrine cells in prostate tumors (27) , binds to G protein-coupled receptors expressed by CaP tumors (28) and cells (29) , and induces transactivation of the epidermal growth factor receptor in PC-3 cells (30) . The following studies were performed to establish the activity of bombesin in PC-3 and Du145 cells and to compare its effects to those of 18:1 LPA.
Immunoblotting was used to test the effects of bombesin on signal transduction pathways in PC-3 and Du145 cells (Fig. 1) . The effects of bombesin were compared with those of 18:1 LPA. FAK and ERKs have been established as downstream targets of both bombesin and LPA. In Fig. 1A , tyrosine phosphorylation of FAK was examined in PC-3 cells by immunoblotting for phospho-FAK. Bombesin and 18:1 LPA both induced FAK phosphorylation by 5 min. The bombesin response was attenuated by 15 min, whereas the LPA response was not. In Fig.  1B , the effects of bombesin and 18:1 LPA on activation of Raf, MEK, ERK, and p90 rsk , components of the ERK MAPK pathway, were examined in PC-3 and Du145 cells by immunoblotting for the phosphorylated active kinases. In PC-3 cells, bombesin and 18:1 LPA similarly induced phosphorylation of Raf, MEK1/2, ERK, and p90 rsk at 10 min. In Du145 cells, 18:1-LPA was more efficacious than bombesin in activating the ERK cascade. In summary, bombesin and 18:1 LPA activate two of the same signal transduction pathways in PC-3 and Du145 cells.
Production of LPA by CaP Cells-LPA production was first assessed using an isotopic assay (20 . These data suggested that the LPA in the medium is not cell-associated. To further exclude this possibility, we incubated attached cells in fresh medium for times up to 60 min and then sedimented and counted detached cells. The total number of detached cells collected from one well was less than 60 from a total of 3 ϫ 10 5 cells seeded. This result suggested that cell-associated LPA contributed negligibly to LPA in the medium. Having established an assay for LPA production, we examined whether LPA levels were regulated by agonist. Fig. 2C shows that LPA in the medium was increased by treatment of PC-3 cells with 100 nM bombesin for 20 min. The effects of bombesin on LPA in both cells and medium will be further addressed below.
We next sought to identify the endogenous LPAs secreted by CaP cells. MS has been used to detect and analyze phospholipid and sphingolipid species (31, 32) . Because this work has shown that 18-acyl-LPAs are abundant in biological samples, we focused our efforts on identifying these species in CaP cell culture medium. After using TLC to separate LPA from other lipids, we extracted LPA from the TLC plate and identified LPA species by ESI-MS. In Fig. 3A , acyl-LPAs with 18-carbon fatty acid chains (central m/z at 435) were identified from the medium of PC-3 cells. A species with m/z of 435.3, corresponding to that of 18:1 (oleoyl) LPA, is the major peak detected in this spectrum. MS/MS was further used to verify the structure of peak 435.3.
In Fig. 3B , the fragments with m/z of 171 and 153 represent the glycerol phosphate backbone of LPA with or without an oxygen atom at sn-1 or sn-2, respectively. MS/MS has been used by others under the same conditions to confirm the structure of acyl-LPAs, with similar fragments observed (33) . In Du145 medium, we used the same approach to detect and verify the presence of 18:1 LPA as a major species (data not shown). In summary, bombesin increases LPA production in PC-3 and Du145 cells. ESI-MS revealed that 18:1 LPA is generated by both cell lines.
Effects of Bombesin on LPA Production and PLD Activity-
The results presented above demonstrated that bombesin can increase production of LPA in CaP cells. It has been reported that PLD and PLA 2 , which may contribute to LPA generation, are rapidly activated by bombesin in other cell lines (34, 35) . 3 H]oleic acid, were run in parallel on the TLC plate and exposed for autoradiography. The autoradiogram of the TLC plate is shown. In C, PC-3 cells were labeled with [ 3 H]lyso-PAF as described above. Washed cells were incubated in the absence or presence of 100 nM bombesin for 20 min. LPA was extracted and separated, using duplicate dishes for each condition as described for A. The autoradiogram of the portion of the plate containing the LPA band is shown.
The kinetics and location (cells versus medium) of bombesininduced LPA production were therefore examined in more detail. PC-3 and Du145 were treated with 100 nM bombesin for varying times, and LPA generation was assessed in cells and medium, using the isotopic assay (Fig. 4) . As shown in the top left panel, bombesin induced a maximal increase in LPA in PC-3 cells at 10 -20 min. In the top right panel, bombesin caused a more gradual increase in LPA in PC-3 medium, with a significant (p ϭ 0.012) increase seen at 40 min. The data in this experiment were normalized to total lipid recovered; note that LPA represents a higher percentage of the total lipid in medium than in cells. This was expected, because the cells have a higher background of total labeled lipid (Fig. 2B) . As noted previously, the total amount of LPA is greater in cells than in medium. A dose-response study established that LPA production in PC-3 cells was maximal with 100 nM bombesin (data not shown). The bottom panels show that bombesin increases LPA in Du145 cells and medium, with kinetics similar to those observed in PC-3 cells.
The effects of bombesin on PLD activity were next examined using PC-3 cells. PEt is a relatively stable PLD product produced by a transphosphatidylation reaction in the presence of ethanol, whereas PA is the product of the hydrolysis reaction. Fig. 5 (upper panel) indicates that PEt formation was stimulated by bombesin at 10 and 20 min. PEt levels decreased by 40 min, suggesting that the response to bombesin was transient. FIG. 3 . Mass spectrometry analysis of 18:1 LPA in CaP cell medium. PC-3 cells were serum-starved for 24 h, rinsed in serum-free medium, and then incubated for 1 h in the same medium. The lipids were extracted from the medium and separated by TLC as described for Fig. 2 but without isotopic labeling. The LPA band was scraped from the TLC plate and then extracted. ESI-MS and MS/MS were performed using a LCQ TM ion trap mass spectrometer equipped with an ESI source (Finnigan Corp.). The samples were delivered into the ESI source using a syringe pump via direct infusion. The mobile phase was methanol:H 2 O (1:1, v/v); the flow rate was 5 l/min. LPA was detected using the negative ion mode. The collision energies were 28% for MS/MS. A shows the spectrum, centered on 435 (i.e. the region containing 18-carbon acyl-LPAs). The m/z 435.3 corresponds to that of 18:1-acyl-LPA. B shows the MS/MS spectrum of the 435.3 peak, confirming the structure as 18:1-acyl-LPA by fragmentation to glycerophosphate.
As shown in the lower panel, PA was elevated by 10 min and decreased by 20 min. The earlier decline in PA, as compared with PEt, likely reflects its more rapid metabolism to products such as diglyceride and LPA. In summary, bombesin induces LPA production in PC-3 and Du145 cells. LPA appears first in the cells and later in the medium. The kinetics of bombesininduced PLD activation and cellular LPA production are similar. In Fig. 7 , PLD activation was tested in Du145 cells incubated with different species of LPA. Among the five LPAs tested, 18:1 LPA was most effective in stimulating PLD, followed in decreasing order by 14:0, 16:0, and 18:0 LPA. This order of efficacy was slightly different from that seen for ERK activation (Fig. 6) , suggesting that different profiles of LPA receptors may mediate the two responses. Nonetheless, 18:1 LPA was the most efficacious for activation of both ERK and PLD.
Effects of LPAs with Different Substituents on ERK MAPK
Effects of Bombesin on LPA Response-As one approach to address whether the LPA produced in response to bombesin is capable of activating LPA receptors, we tested whether cross- talk occurs between bombesin and LPA receptors. Following ligand binding, G protein-coupled receptors are desensitized by a complex series of events involving receptor phosphorylation as well as endocytosis (37) . We reasoned that, if the LPA generated in response to bombesin was able to activate LPA receptors, then heterologous desensitization of LPA response should be observed in bombesin-treated cells. Du145 cells were treated with either bombesin or 18:1 LPA for 2 h and then treated with either bombesin or 18:1 LPA for 15 min. ERK phosphorylation was assessed by immunoblotting for phospho-ERK. As shown in Fig. 8A (left lanes) , 15 min of incubation with bombesin induced only modest ERK activation, whereas LPA and phorbol 12-myristate 13-acetate elicited robust responses. As noted previously (Fig. 1B) , LPA is more effective than bombesin at inducing ERK activation in Du145 cells. Pretreatment with LPA (right lanes) completely inhibited subsequent response to LPA (homologous desensitization). Bombesin pretreatment (center lanes) likewise inhibited the subsequent response to bombesin (homologous desensitization). Most importantly, bombesin pretreatment resulted in partial inhibition of the response to 18:1 LPA (heterologous desensitization). Quantitation by densitometry revealed that LPA-induced ERK activation was reduced by 32.1 Ϯ 6.5% (n ϭ 3 separate experiments; p Ͻ 0.01) in cells pretreated with bombesin. In contrast, the response to phorbol 12-myristate 13-acetate was not significantly inhibited by pretreatment with either bombesin or LPA (center and right lanes), suggesting that heterologous desensitization did not occur at a step downstream of Ras (38) .
The partial extent of desensitization to LPA may reflect partial occupation of LPA receptors, with the caveat that the heterologous desensitization induced by bombesin probably involves more than one mechanism and is not solely due to LPA generation. In Fig. 8A , the concentrations of LPAs achieved after bombesin treatment appeared to represent less than 10 M, the concentration eliciting complete desensitization. To further address this issue, a dose-response study (Fig. 8B ) was performed to determine the concentration of 18:1 LPA required to achieve homologous desensitization. Partial desensitization was observed in cells preincubated with 0.1 M 18:1 LPA, whereas complete desensitization required 1 M 18:1 LPA. In this experiment, the inhibition of LPA response seen in bombesin-treated cells was in the range of that observed between 10 and 100 nM 18:1 LPA. As shown previously (Fig. 6B) , such concentrations of 18:1 LPA (Ͻ1 M) elicit minimal ERK activation during a 15-min incubation. Consistent with these data, the ERK activation elicited by bombesin in Du145 cells (Fig.  8A ) was much smaller in magnitude than that elicited by 10 M 18:1 LPA. Thus, the desensitization data suggested that transactivation of LPA receptors might occur in response to bombesin treatment.
Quantitation of Bulk LPA Levels-We next sought to determine the molar concentration of LPA present in the medium of CaP cells treated with and without bombesin. For this purpose, we utilized a radioenzymatic assay for LPA developed by Saulnier-Blache et al. (21) . This assay employs bacterially expressed LPA acyltransferase as a reagent to convert unlabeled LPA to [ 14 C]PA in the presence of [ 14 C]oleoyl-CoA. The enzyme utilizes both acyl-and alkyl-linked LPAs as substrate. Lipids extracted from PC-3 cells and medium incubated in the absence and presence of 100 nM bombesin were utilized in the radioenzymatic assay. As shown in Fig. 9A , incubation of cells with bombesin for 60 min increased LPA levels in both compartments. The total level of LPA in the cells was consistently severalfold higher than in the medium, as suggested earlier by the results of the isotopic assay (Fig. 2) . To verify detection of LPA, medium was treated with PLB prior to analysis. This treatment resulted in a decrease in PA production (Fig. 9A) , consistent with the fact that PLB removes the 1-acyl substituent of LPAs (21) . The observation that the LPA signal was (Fig. 9B) . Using this information, the total levels of LPA in medium and cells were as follows (mean Ϯ S.D., n ϭ 2): medium from untreated cells, 2.8 Ϯ 0.7 pmol; In B, the cells were incubated with 100 nM or with varying doses of LPA for 2 h as described for A and then incubated with and without 10 M 18:1 LPA for 15 min. Whole cell extracts were immunoblotted for phospho-ERK and total ERK. The lanes are designated by arrows as described for A. The quantitated results, determined by densitometry, are indicated on the figure; phospho-ERK was normalized to total ERK and expressed as a percentage of the value for untreated control cells. medium from bombesin-treated cells, 10.1 Ϯ 3.1 pmol; untreated cells, 29.7 Ϯ 18.9 pmol; and bombesin-treated cells, 35.5 Ϯ 22.6 pmol. As indicated previously, bombesin increased LPA levels in the medium; cellular LPA levels were not significantly different between untreated and bombesin-treated at the time point tested (60 min). The molar concentrations of LPA in the medium (mean Ϯ S.D., n ϭ 2) were calculated to be 0.24 Ϯ 0.06 nM (untreated), 0.84 Ϯ 0.26 nM (bombesin-treated), and 0.15 Ϯ 0.01 nM (bombesin-treated, after PLB). These quantitative data confirm that bombesin increases LPA production by CaP cells.
Biological Activity of LPA Secreted by CaP Cells-LPA has been shown to induce mobilization of intracellular calcium stores in cells expressing LPA receptors (25) . We examined the ability of LPAs extracted from CaP cell medium to induce calcium mobilization when added back to CaP cells. PC-3 cells were incubated for 1 h in the absence and presence of 100 nM bombesin. LPA was extracted from the medium and then added back to serum-starved PC-3 cells. Calcium mobilization was analyzed using a fluorometric imaging plate reader (Molecular Devices). To correct for any losses in LPA resulting from the extraction procedure or for any interference by components extracted from the medium, 18:1 LPA was added to fresh medium and subjected to the same extraction protocol prior to use as a standard. The dose response for calcium mobilization in PC-3 cells incubated with extracted 18:1 LPA is shown in Fig. 10A . Note that the curve is unusually steep, suggesting a "threshold" effect. This may reflect inefficient recovery of low levels of LPA from medium. In Fig. 10B , the response of PC-3 cells to lipid extracted from medium of cells incubated with and without bombesin for 60 min is shown. Calcium mobilization was observed using lipid extracted from medium of bombesintreated cells. Under the conditions used here, in which lipid extracts from multiple dishes of cells were pooled and concentrated, the maximal response to lipids from medium of bombesin-treated PC-3 cells was ϳ20% of that seen with 1 M 18:1 LPA (data not shown). There was little or no response to lipid extracted from the medium of untreated cells, suggesting that the level of LPA present was below the limit of detection of the calcium mobilization assay under the conditions employed. The dose-response curve for 18:1 LPA (Fig. 10A ) was used to estimate the concentration of LPA present in medium from bombesin-treated PC-3 cells. The value obtained from this calculation was in the low nanomolar range, consistent with the results of the radioenzymatic assay. Fig. 10C shows that treatment of medium from bombesin-treated cells with PLB prior to lipid extraction resulted in a loss of calcium response, indicating that LPA was responsible for the effect. In summary, the data presented above support the hypothesis that LPA, generated in response to bombesin, can act as an autocrine mediator in CaP cells.
DISCUSSION
In the present study, we have characterized LPA production and response in human prostate cancer cells. We provide evidence that 18:1 LPA can act as an autocrine mediator for human prostate cancer cells. To our knowledge, this is the first formal demonstration that LPA can signal in an autocrine manner.
To document that LPA acts an autocrine mediator, it is necessary to demonstrate, in a single cell type, 1) expression of LPA receptors, 2) response to LPA, 3) production of biologically active LPA, and 4) response to endogenous LPA. Our previous work showed that both PC-3 and Du145 cells express the LPA receptors LPA 1 /Edg2 and LPA 2 /Edg4 (17).
2 Work from our lab has also shown that 18:1 LPA induces proliferation in both PC-3 (17) 2 and Du145 2 cells. In the current study, using the two CaP cell lines, we show that 18:1 LPA is present in CaP cell medium, that production of bioactive LPA is increased by bombesin, and that bombesin causes desensitization of LPA receptors.
Bombesin and the related peptide neurotensin are expressed and secreted by neuroendocrine cells in prostate carcinomas and may contribute to progression of this disease (39) . In this study, we observed that bombesin and 18:1 LPA both induce FAK phosphorylation (PC-3) and activation of the ERK MAPK FIG. 9 . Radioenzymatic assay for bulk LPA levels. In A, serum-starved PC-3 cells were incubated with and without 100 nM bombesin (BB) for 60 min. The medium and cells were collected, and the lipid extracts were prepared. The samples were analyzed for LPA levels using a radioenzymatic assay as described under "Experimental Procedures." A standard curve was run in the same experiment, using 18:1 LPA. One lane shows medium from bombesin-treated cells that was incubated with PLB prior to extraction and assay. The product, [ 14 C]PA, was resolved by TLC and subjected to autoradiography. All of the lanes shown are from the same experiment and were exposed to film in parallel. In B, the results of standard curves run in four separate experiments were analyzed by densitometry, combined, and fit by linear regression (GraphPad PRISM). Each point represents the mean Ϯ S.E. (n ϭ 4), except for the 5 pmol value, which was from a single experiment.
pathway (PC-3 and Du145). Bombesin-mediated ERK activation may be mediated in part by LPA. However, the extent of the role of LPA in bombesin response will be difficult to assess until LPA antagonists with high affinity and specificity are developed. The effects mediated directly by the gastrin releasing peptide receptor, the bombesin receptor expressed in CaP cells, cannot be discounted. For example, the acute effect of bombesin on FAK phosphorylation in PC-3 cells (Fig. 1A) is FIG. 10 . Effects of LPA on calcium mobilization in CaP cells. Serum-starved PC-3 cells were incubated with and without bombesin for 60 min. The medium was collected, and the lipid extracts were prepared as described under "Experimental Procedures." The lipid extracts were concentrated and then applied to serum-starved PC-3 cells in a calcium mobilization assay as described under "Experimental Procedures." A presents a dose-response experiment analyzing the effects of exogenous 18:1 LPA (extracted from medium) on calcium mobilization. The maximal calcium response is plotted on the y axis. In B, the time course of the response of PC-3 cells to lipid extracts from medium of untreated and bombesin-treated PC-3 cells is shown. Lipid extracted from fresh medium that had not exposed to cells was used as a negative control. Each data point represents the mean of values obtained from five or six replicate wells. C shows the time course of the response of PC-3 cells to lipids from medium of bombesin-treated cells that had been treated with or without PLB. The medium was incubated with PLB prior to lipid extraction. The lipid extracted from untreated cells and subsequently treated with PLB was used as a negative control. Each data point represents the mean of values obtained from five or six replicate wells. more prominent than that of LPA. Given that LPA itself can induce LPA production in CaP cells (6) , additional positive autocrine feedback may take place. Moreover, because both bombesin (30) and LPA (19) have been reported to induce transactivation of the epidermal growth factor receptor in PC-3 cells, cross-talk can potentially occur between bombesin and LPA receptors at several levels.
We observed that PC-3 and Du145 cells can release LPA into the cell culture medium and that this response is agonistregulated. LPA appeared first in the cells and then in the medium. The bombesin-induced increase in cellular LPA was relatively small in magnitude (Figs. 4 and 9) . There are at least two possible explanations for this result. First, because the medium was changed immediately prior to the incubation, it contained relatively low basal levels of LPA and other lipids. Thus, an increase in LPA was more readily detected in the medium. Second, cell-associated LPA may be rapidly metabolized to PA and/or MG by acyl-transferase and lipid phosphate phosphatases (40) . Although extracellular LPA can also be degraded by lipid phosphate phosphatases (41) , such degradation may be limited by dilution under the conditions used here. It remains to be determined whether LPA is actively secreted or is generated on the outer face of the plasma membrane where it can be shed into the extracellular space.
It has been proposed that PLD and PLA 2 are involved in synthesis of sn-1 LPAs. PLD hydrolyzes phosphatidylcholine to PA, which can be further hydrolyzed to LPA by PLA 2 . The existence of sn-2 LPAs in biological samples suggests that PLA 1 may also participate in LPA production. It has been shown that sn-2 LPAs are preferred ligands for LPA 3 (42) . Our MS analysis did not distinguish between sn-1 and sn-2 18:1 LPAs. Alternative pathways for LPA generation are that a lyso-PLD may generate LPA from lysophospholipids (43) or that monoglyceride kinases may generate LPA from MG (44). Our results are consistent with a role for PLD in LPA production, because bombesin-stimulated PLD activity and LPA production occur with similar kinetics. Interestingly, 18:1 LPA also induces PLD activation (Fig. 7 and Ref. 16 ) and LPA production (6) in CaP cells. However, further studies will be needed to address the enzymatic pathways responsible for agonist-induced LPA production.
Our results show that 18:1 LPA is the most abundant 18-carbon LPA species present in medium from PC-3 and Du145 cells. Others have reported that 16:0, 18:1, 18:0, and 18:2 acyl-LPAs are most prevalent in plasma from ovarian cancer patients (33) . Both saturated (18:0 and 16:0) and unsaturated (18:1, 18:2, and 20:4) fatty acids are present in acyl-LPAs from activated platelets (45, 46) . Further studies are needed to characterize and quantitate the full range of LPAs produced by CaP cells and to determine whether particular species are induced by agonists.
This study confirms our previous finding (20) that lyso-PAF, an alkyl-linked lipid, can serve as precursor for LPA production. We have not yet been able to verify the presence of alkyl-LPAs in our samples by MS, perhaps because of a relatively low level of these species. Alkyl-linked LPAs comprise only 10.6% of total LPA in rat brain (47) . The fact that alkyland acyl-LPAs can desensitize each other's responses suggests interaction with a common receptor(s) (47, 48) . However, although alkyl-LPAs are 30-fold more potent than acyl-LPAs in inducing platelet aggregation (49 -51), they have similar or lower potency in inducing calcium mobilization in Sf9 cells expressing LPA 1 , LPA 2 , and LPA 3 and in human cancer cells (42, 48) .
To examine the relative activity of 18:1 LPA, we tested the ability of 6:0, 14:0, 16:0, 18:0, and 18:1 acyl-LPAs to activate signal transduction. The two variables tested were the presence of a double bond and the length of the substituent. In our hands, the presence of one double bond in 18:1 LPA increases the efficacy of LPA-induced ERK activation in both PC-3 and Du145 cells. The double bond can enhance LPA solubility (15) , which may contribute to increased activity. However, this is not the only factor involved, because 18:0 LPA was less efficacious than 18:1 LPA at all doses tested. Although our results could suggest that 18:0 LPA is a partial agonist, it will be important to show that 18:0 and 18:1 LPAs act at the same receptor(s). Our results confirm previous findings that the length of the fatty acid is important for the activity of LPA (15, 52, 53) . Among the tested LPAs with saturated fatty acid chains of varying length, 6:0 LPA did not activate ERK or PLD in Du145 cells, whereas all tested LPAs with substituents of 14 carbons or more induced activation of ERK and PLD. Based on a model developed for S1P 1 /Edg1 (54) and extended to LPA 1 / Edg2 (55), the substituent is positioned between the transmembrane domains of the receptor, providing multiple potential sites for ligand-receptor interaction. Additional modeling of receptor-ligand docking may provide useful information concerning the role of the double bond and chain length.
Bandoh et al. (42) reported that LPA receptors are differentially activated by different LPA species. Their results predict that at the concentration of 10 M used in our study, 18:1 LPA will activate LPA 1 , LPA 2 , and LPA 3 , 16:0 and 18:0 LPA will activate LPA 2 and LPA 3 , and 14:0 LPA will activate only LPA 2 . Because Du145 and PC-3 cells express both LPA 1 and LPA 2 , 2 they are predicted to respond to all of the 14-, 16-, and 18-carbon LPAs tested. Because it has been suggested that LPAinduced proliferation may be mediated through novel receptors (56) , continued characterization of LPA receptors will be important.
Several approaches were used to determine whether the concentrations of LPA produced by CaP cells were sufficient to elicit a cellular response. First, our data suggest that the levels of LPA generated in response to bombesin are sufficient to activate LPA receptors, as evidenced by heterologous desensitization. Receptor desensitization has been used by others as an index of agonist binding to LPA (36) and S1P (5) receptors. Second, an assay for bulk LPA revealed that nanomolar concentrations of LPA were present in medium from stimulated cells. Third, a calcium mobilization assay confirmed that lipid extracted from the medium was capable of inducing a cellular response consistent with nanomolar concentrations of LPA. Although submicromolar concentrations of 18:1 LPA can elicit calcium mobilization, micromolar concentrations are required for maximal ERK activation (Fig. 6 ), receptor desensitization (Fig. 8) , and mitogenesis (16) . The reasons for these discrepancies have not been completely elucidated. It is possible that LPA does not need to be released from cells to act as an autocrine mediator. In other words, LPA generated within the plasma membrane may bind to LPA receptors present in the vicinity (6) . In this scenario, if the concentration of LPA in the microenvironment of the receptor is sufficiently high, cellular responses may be observed prior to accumulation of LPA in the extracellular space. In contrast, the ability of LPA to act as a paracrine mediator is anticipated to be directly correlated with its extracellular concentration. These issues remain to be fully addressed. The findings reported herein provide the basis for further studies of the role of LPA as an autocrine mediator. Because LPA can be generated in response to a variety of agonists and because most cells express LPA receptors, participation of the "LPA axis" in mitogenic signal transduction is potentially of widespread importance.
